Matches in SemOpenAlex for { <https://semopenalex.org/work/W144631857> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W144631857 endingPage "17" @default.
- W144631857 startingPage "307" @default.
- W144631857 abstract "Recent structure-activity relationship studies emphasize the critical role of topoisomerase II-mediated DNA cleavage on the cytotoxic activity of anthracycline anti-tumor antibiotics. Such studies have also given evidence of the peculiar features of the drug interference with DNA topoisomerase II activity. In contrast to other cytotoxic topoisomerase II inhibitors (acridines, epipodophyllotoxins), anthracyclines produce persistent DNA cleavable complexes. This property is more evident with doxorubicin derivatives than with daunorubicin derivatives. The strength of DNA binding apparently does not correlate with the stimulatory effect of anthracyclines on topoisomerase II-mediated DNA cleavage and with their cytotoxic potency. However, drug intercalation is still required for optimal drug activity. Such an observation suggests that the specific mode of DNA interaction, rather than the strength of binding, is important in determining the cytotoxic potency. The extent of anthracycline-induced cleavage results from a balance between a stimulation and a suppressive effect of the drug on topoisomerase II DNA cleavage. Anthracyclines are sequence selective in the induction of DNA cleavage by purified topoisomerase II. Despite the extensive effort in developing DNA intercalating agents as anti-tumor drugs, the limited success of such an approach could be rationalized in terms of the still inadequate 'rational design', since the molecular basis of specific drug-DNA topoisomerase II interaction (e.g. sites of cleavage, cell response to DNA damage, etc.) is not completely understood. Such studies indicating structural requirements in anthracycline molecules, which are critical for specific drug interference with topoisomerase II functions, provide the opportunity to re-examine the mechanism of action of these agents and to design new, more selective derivatives." @default.
- W144631857 created "2016-06-24" @default.
- W144631857 creator A5033312783 @default.
- W144631857 creator A5089156584 @default.
- W144631857 date "1990-11-01" @default.
- W144631857 modified "2023-10-03" @default.
- W144631857 title "DNA topoisomerase II as the primary target of anti-tumor anthracyclines." @default.
- W144631857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1963303" @default.
- W144631857 hasPublicationYear "1990" @default.
- W144631857 type Work @default.
- W144631857 sameAs 144631857 @default.
- W144631857 citedByCount "51" @default.
- W144631857 countsByYear W1446318572012 @default.
- W144631857 countsByYear W1446318572013 @default.
- W144631857 countsByYear W1446318572014 @default.
- W144631857 countsByYear W1446318572015 @default.
- W144631857 countsByYear W1446318572016 @default.
- W144631857 countsByYear W1446318572017 @default.
- W144631857 countsByYear W1446318572018 @default.
- W144631857 countsByYear W1446318572019 @default.
- W144631857 countsByYear W1446318572022 @default.
- W144631857 countsByYear W1446318572023 @default.
- W144631857 crossrefType "journal-article" @default.
- W144631857 hasAuthorship W144631857A5033312783 @default.
- W144631857 hasAuthorship W144631857A5089156584 @default.
- W144631857 hasConcept C121608353 @default.
- W144631857 hasConcept C143425029 @default.
- W144631857 hasConcept C147897179 @default.
- W144631857 hasConcept C151730666 @default.
- W144631857 hasConcept C175156509 @default.
- W144631857 hasConcept C185592680 @default.
- W144631857 hasConcept C203014093 @default.
- W144631857 hasConcept C2776694085 @default.
- W144631857 hasConcept C2776802502 @default.
- W144631857 hasConcept C2778461978 @default.
- W144631857 hasConcept C2778616834 @default.
- W144631857 hasConcept C2781021840 @default.
- W144631857 hasConcept C2781303535 @default.
- W144631857 hasConcept C43369102 @default.
- W144631857 hasConcept C530470458 @default.
- W144631857 hasConcept C54355233 @default.
- W144631857 hasConcept C552990157 @default.
- W144631857 hasConcept C55493867 @default.
- W144631857 hasConcept C86803240 @default.
- W144631857 hasConcept C98274493 @default.
- W144631857 hasConceptScore W144631857C121608353 @default.
- W144631857 hasConceptScore W144631857C143425029 @default.
- W144631857 hasConceptScore W144631857C147897179 @default.
- W144631857 hasConceptScore W144631857C151730666 @default.
- W144631857 hasConceptScore W144631857C175156509 @default.
- W144631857 hasConceptScore W144631857C185592680 @default.
- W144631857 hasConceptScore W144631857C203014093 @default.
- W144631857 hasConceptScore W144631857C2776694085 @default.
- W144631857 hasConceptScore W144631857C2776802502 @default.
- W144631857 hasConceptScore W144631857C2778461978 @default.
- W144631857 hasConceptScore W144631857C2778616834 @default.
- W144631857 hasConceptScore W144631857C2781021840 @default.
- W144631857 hasConceptScore W144631857C2781303535 @default.
- W144631857 hasConceptScore W144631857C43369102 @default.
- W144631857 hasConceptScore W144631857C530470458 @default.
- W144631857 hasConceptScore W144631857C54355233 @default.
- W144631857 hasConceptScore W144631857C552990157 @default.
- W144631857 hasConceptScore W144631857C55493867 @default.
- W144631857 hasConceptScore W144631857C86803240 @default.
- W144631857 hasConceptScore W144631857C98274493 @default.
- W144631857 hasIssue "4" @default.
- W144631857 hasLocation W1446318571 @default.
- W144631857 hasOpenAccess W144631857 @default.
- W144631857 hasPrimaryLocation W1446318571 @default.
- W144631857 hasRelatedWork W2004087697 @default.
- W144631857 hasRelatedWork W2010183849 @default.
- W144631857 hasRelatedWork W2030135253 @default.
- W144631857 hasRelatedWork W2032090647 @default.
- W144631857 hasRelatedWork W2056254035 @default.
- W144631857 hasRelatedWork W2128590787 @default.
- W144631857 hasRelatedWork W2150283119 @default.
- W144631857 hasRelatedWork W2409651531 @default.
- W144631857 hasRelatedWork W2565796763 @default.
- W144631857 hasRelatedWork W3200938066 @default.
- W144631857 hasVolume "5" @default.
- W144631857 isParatext "false" @default.
- W144631857 isRetracted "false" @default.
- W144631857 magId "144631857" @default.
- W144631857 workType "article" @default.